Metolazone for Chronic Kidney Disease
This trial will study how well diuretics work in patients with chronic kidney disease.
- Chronic Kidney Disease
- Kidney Failure
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
What is the enrollment capacity for this clinical research?
"Affirmative. According to the information hosted on clinicaltrials.gov, recruitment for this medical trial is underway; it was initially posted in March 2021 and last revised September 2022. Fifty participants are sought from two different healthcare facilities."
Has this procedure achieved official endorsement from the FDA?
"Our assessment of this treatment's safety is a 2, as it has yet to reach Phase 3 and demonstrate efficacy in clinical trials. However, existing data does indicate that the medication is safe for use."
Is recruitment for this experiment ongoing?
"Affirmative. The clinicaltrials.gov database shows that this medical experiment, posted on March 1st 2021 and amended September 29th 2022, is actively seeking out volunteers. Fifty participants must be sourced from two different locations."
Has this treatment method been examined in prior clinical experiments?
"At present, there are 2 active trials for this treatment but none of them have reached Phase 3 yet. Principal sites offering these clinical studies can be found in New Haven, Connecticut with additional locations participating as well."